The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
FDA Drug Info now has audio podcasts specifically for healthcare professionals. These podcasts include the most recent Drug Safety Communications from FDA. Recently posted healthcare professional podcasts include:
- Ongoing Safety Review of Oral Bisphosphonates and Atypical Subtrochanteric Femur Fractures
- Reduced Effectiveness of Plavix in Patients who are Poor Metabolizers of the Drug
- Ongoing Review of Avandia and Cardiovascular Safety
- Ongoing Safety Review of Invirase and Possible Association with Abnormal Heart Rhythms
- Serious Liver Disorder Associated with the Use of Videx/Videx EC
You can download other FDA Drug Safety Podcasts at: Podcasts for HCP
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@xxxxxxxxxxx.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
